Related Experiment Video
Updated: May 21, 2026

04:32
Sound Source Localization Testing in Single-sided Deafness Following Bone Conduction Intervention
Published on: December 20, 2024
Stability of osseointegrated bone conduction systems in children: a pilot study
Pasquale Marsella1, Alessandro Scorpecci, Riccardo D'Eredità
1Bambino Gesù Children's Hospital, Rome, Italy.
Summary
The novel BI300 TiOblast-coated bone conduction implant shows greater initial stability in children compared to the previous titanium model. Faster osseointegration was not definitively proven, requiring further study in larger pediatric populations.
Area of Science:
- Pediatric Otolaryngology
- Biomaterials Science
- Implantology
Background:
- Assessing bone conduction implant stability and osseointegration in pediatric patients is crucial for successful auditory rehabilitation.
- Comparing novel implant technologies to existing ones informs clinical practice and device development.
Purpose of the Study:
- To objectively evaluate the stability and osseointegration of the new TiOblast-coated BI300 implant in children.
- To compare the BI300 implant's performance against the previous generation as-machined titanium implant.
Main Methods:
- A prospective, multicenter, nonrandomized study involving 10 pediatric subjects (<16 years) undergoing single-stage implantation.
- Five subjects received the control (as-machined titanium) implant, and five received the test (BI300 TiOblast-coated) implant.
- Implant stability and osseointegration were measured using resonance frequency analysis over 6 months.
Main Results:
- The BI300 implant demonstrated higher average stability intraoperatively and up to 6 months post-surgery compared to the control.
- Both implant types showed increased stability over the follow-up period, though this increase was not statistically significant.
- Faster osseointegration for the BI300 was not definitively confirmed.
Conclusions:
- The BI300 implant system offers superior primary stability in pediatric patients compared to the previous generation.
- While faster osseointegration requires further verification, the BI300 may enhance the safety and reduce failure rates in single-stage surgeries.
- Larger studies are needed to confirm the potential for earlier processor loading with the BI300 implant.
